GigaMune
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$400,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GigaMune is a biotechnology company developing a pipeline of in vivo cell therapies for cancer and inherited blood disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GigaMune Comparables
Compare GigaMune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ensoma | 82% | |
| Alaya.bio | 79% | |
| Shenzhen Genocury Biotechnology Co., Ltd. | 78% |
GigaMune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Pre Seed | May 30, 2023 | ||||
| Grant | Aug 1, 2021 | ||||
| Convertible Debt | Apr 12, 2019 |
GigaMune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Newsight Tech Angels | Pre Seed |
| Bioverge | Pre Seed |
| Sand Hill Angels | Pre Seed |
| Boost VC | Pre Seed |
| Reinforced Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors increased 61% MoM.
- Sep 15, 2025
$400K round led by the National Cancer Institute.
GigaMune Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GigaMune's valuation, stock price, and market status.
Is GigaMune a public or private company?
GigaMune is a private company.
What is the current stock price of GigaMune?
GigaMune is a private company with no public stock price. No recent secondary market data is available.
How much is GigaMune worth (valuation)?
Valuation information for GigaMune is not publicly available.
Can I buy GigaMune stock?
GigaMune shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GigaMune's last funding round?
GigaMune's most recent funding round was Grant on September 15, 2025.
Who are the main investors in GigaMune?
Key investors in GigaMune include National Cancer Institute.
Will GigaMune IPO soon?
No public IPO plans have been announced for GigaMune.
How can I track GigaMune secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GigaMune's secondary market activity and sign up for updates.